
Commentary|Articles|August 26, 2026
Beyond the itch: Recognizing vision-threatening eye allergy in children
Author(s)Kassi Filkins, Angela Zhu, MD
Angela Y. Zhu, MD, of Bascom Palmer Eye Institute, explains how to distinguish eye allergy from vision-threatening VKC and AKC in children and when steroid-sparing therapy and referral are warranted.
Advertisement
Advertisement
Children's Eye Health and Safety Month centers largely on vision screening and injury prevention, but allergic eye disease is a quietly common—and sometimes vision-threatening—part of pediatric eye care. Seasonal and perennial allergic conjunctivitis affect a large share of children, while more severe forms such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) can progress to shield ulcers, corneal scarring, and lasting visual compromise if missed.
Related to this article

Cataract original papers on intracameral antibiotics and IOL power, a guideline-based case symposium, and ocular surface sessions headline AAO 2026.

Serena Salvatore, MD, discusses the retinal laser training gap, persistent laser myths, simulation and practical advice for safer laser at EURETINA 2026.

Nimesh Patel, MD, urges the FDA to reconsider SYD-101 as pediatric myopia drives earlier retinal damage in US children.

Aldeyra Therapeutics will submit a FDRR to the FDA for reproxalap, an investigational drug or dry eye disease.

Coats, OD, FAAO, explains how neurotrophic keratitis, demodex, cosmetic habits and mucus fishing complicate dry eye disease.

The Wilmer Eye Institute's new Glaucoma Division chief discusses mentoring junior faculty, multicenter trials, and optic nerve regeneration.

Eyes on September 2026: ESCRS insights, gene therapy wins, and the push to treat myopia as a disease
September was one of the busiest months of the year in eye care—From ESCRS to Eyecon
Advertisement
Advertisement

